“The data show that both updated vaccines “Pfizer-BioNTech and Moderna against covid, they also neutralize the Omicron 5 and Ba.2.75 Centaurus variants. Approved yesterday by the European Medicines Agency Ema, “they trigger strong immune responses against Omicron BA.1 and the original Sars-CoV-2 virus in previously vaccinated people”, explains Marco Cavaleri, Ema’s Head of Vaccines and Covid-19 Therapeutic Products , adding: “Preliminary data also indicated that the antibodies generated by these adapted vaccines are capable of neutralizing other Omicron variants, including BA.2.75,” dubbed Centaurus on social media and intercepted specifically in India, “and, importantly, Omicron 5 “.
“In fact, we have seen so far that all adapted vaccines are showing improved immune responses to Omicron sub-lineages that have recently circulated, regardless of the concern variant that was incorporated into the vaccine.” Cavaleri pointed out during the press briefing.
“Adapted vaccines should be used to revaccinate some categories at risk: the elderly, those with other diseases, those at risk of developing a serious Covid disease, immunocompromised people” but also “pregnant women and health workers” , suggested the EMA.